CDH1 and breast cancer: However, BC cells with the more mesenchymal phenotype (MDA-MB-468) were found to overexpress N-cadherin, whereas BC lines with an epithelial phenotype (T47D, MCF7) responded to HDI treatment through a significant increase in E-cadherin expression.